share_log

Goldman Sachs Maintains Buy on Edwards Lifesciences, Raises Price Target to $90

Benzinga ·  Dec 6 01:34  · Ratings

Goldman Sachs analyst David Roman maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $81 to $90.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment